Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.

The SARS-CoV-2 pandemic highlights the need for a detailed molecular understanding of protective antibody responses. This is underscored by the emergence and spread of SARS-CoV-2 variants, including Alpha (B.1.1.7) and Delta (B.1.617.2), some of which appear to be less effectively targeted by curren...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rui Yin, Johnathan D Guest, Ghazaleh Taherzadeh, Ragul Gowthaman, Ipsa Mittra, Jane Quackenbush, Brian G Pierce
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/e124a4e516d34a9fbdf3e223838d242e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e124a4e516d34a9fbdf3e223838d242e
record_format dspace
spelling oai:doaj.org-article:e124a4e516d34a9fbdf3e223838d242e2021-12-02T19:58:14ZStructural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.1553-734X1553-735810.1371/journal.pcbi.1009380https://doaj.org/article/e124a4e516d34a9fbdf3e223838d242e2021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009380https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358The SARS-CoV-2 pandemic highlights the need for a detailed molecular understanding of protective antibody responses. This is underscored by the emergence and spread of SARS-CoV-2 variants, including Alpha (B.1.1.7) and Delta (B.1.617.2), some of which appear to be less effectively targeted by current monoclonal antibodies and vaccines. Here we report a high resolution and comprehensive map of antibody recognition of the SARS-CoV-2 spike receptor binding domain (RBD), which is the target of most neutralizing antibodies, using computational structural analysis. With a dataset of nonredundant experimentally determined antibody-RBD structures, we classified antibodies by RBD residue binding determinants using unsupervised clustering. We also identified the energetic and conservation features of epitope residues and assessed the capacity of viral variant mutations to disrupt antibody recognition, revealing sets of antibodies predicted to effectively target recently described viral variants. This detailed structure-based reference of antibody RBD recognition signatures can inform therapeutic and vaccine design strategies.Rui YinJohnathan D GuestGhazaleh TaherzadehRagul GowthamanIpsa MittraJane QuackenbushBrian G PiercePublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 9, p e1009380 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Rui Yin
Johnathan D Guest
Ghazaleh Taherzadeh
Ragul Gowthaman
Ipsa Mittra
Jane Quackenbush
Brian G Pierce
Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
description The SARS-CoV-2 pandemic highlights the need for a detailed molecular understanding of protective antibody responses. This is underscored by the emergence and spread of SARS-CoV-2 variants, including Alpha (B.1.1.7) and Delta (B.1.617.2), some of which appear to be less effectively targeted by current monoclonal antibodies and vaccines. Here we report a high resolution and comprehensive map of antibody recognition of the SARS-CoV-2 spike receptor binding domain (RBD), which is the target of most neutralizing antibodies, using computational structural analysis. With a dataset of nonredundant experimentally determined antibody-RBD structures, we classified antibodies by RBD residue binding determinants using unsupervised clustering. We also identified the energetic and conservation features of epitope residues and assessed the capacity of viral variant mutations to disrupt antibody recognition, revealing sets of antibodies predicted to effectively target recently described viral variants. This detailed structure-based reference of antibody RBD recognition signatures can inform therapeutic and vaccine design strategies.
format article
author Rui Yin
Johnathan D Guest
Ghazaleh Taherzadeh
Ragul Gowthaman
Ipsa Mittra
Jane Quackenbush
Brian G Pierce
author_facet Rui Yin
Johnathan D Guest
Ghazaleh Taherzadeh
Ragul Gowthaman
Ipsa Mittra
Jane Quackenbush
Brian G Pierce
author_sort Rui Yin
title Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
title_short Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
title_full Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
title_fullStr Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
title_full_unstemmed Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.
title_sort structural and energetic profiling of sars-cov-2 receptor binding domain antibody recognition and the impact of circulating variants.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/e124a4e516d34a9fbdf3e223838d242e
work_keys_str_mv AT ruiyin structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT johnathandguest structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT ghazalehtaherzadeh structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT ragulgowthaman structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT ipsamittra structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT janequackenbush structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
AT briangpierce structuralandenergeticprofilingofsarscov2receptorbindingdomainantibodyrecognitionandtheimpactofcirculatingvariants
_version_ 1718375811392733184